Practice with national-level exam (FACT, FACT Plus, NET, CUET, etc.) mocks, learn from structured notes, and get your doubts solved in one place.
Cocaine alkaloid chemistry, crack vs powder, cutting-agent profiles and isotope-ratio source attribution; the amphetamine family (amphetamine, methamphetamine, MDMA, MDA), enantiomer chemistry that distinguishes pharmaceutical from clandestine origin; and the clandestine synthesis routes (Leuckart, Birch / Nazi method, P2P, pseudoephedrine reduction) that drive precursor scheduling worldwide.
Last updated:
Stimulants as a drug class span two distinct chemical families whose casework significance is equally global but whose chemistry, supply chains, and forensic analytical challenges are sharply different. Cocaine is a plant-derived alkaloid, extracted from Erythroxylum coca leaves cultivated in South America, refined through a well-characterised sequence of solvent extractions and acid-base chemistry, and distributed through transnational trafficking networks with a forensic fingerprint that can be traced back to source regions by stable isotope ratio mass spectrometry. The amphetamine family, by contrast, is entirely synthetic: small-molecule phenethylamines that can be manufactured in clandestine laboratories from accessible precursors, in quantities ranging from a few grams in a makeshift home lab to the tonne-scale methamphetamine production documented in Myanmar's Golden Triangle and, historically, in the industrial-scale Mexican superlabs operated by the Sinaloa Cartel.
Globally, the UN Office on Drugs and Crime's World Drug Report 2024 estimates that stimulants are now the most commonly used controlled substance class by person-count, ahead of cannabis in several regions: methamphetamine dominates East and Southeast Asia, amphetamine sulphate dominates the Middle East (particularly the Captagon tablet networks supplying Syria and Saudi Arabia), cocaine dominates North America and Western Europe, and MDMA is a persistent festival and nightlife drug across Europe, Australia, and urban North America.
For the forensic chemist, these substances require mastery of three analytical areas that do not apply to opioid casework in the same way: enantiomer separation (d- vs l-methamphetamine, to determine pharmaceutical vs clandestine origin); stable isotope ratio MS for geographic source attribution (Colombia vs Peru vs Bolivia for cocaine); and precursor and synthesis route chemistry (which clandestine route produced this batch, and which precursors are therefore controlled). This topic covers all three.
Cocaine hydrochloride and crack cocaine are the same molecule in two different salt forms, but the chemistry of their interconversion defines entirely different user populations, routes of administration, and cutting-agent profiles in casework.
Cocaine is the principal alkaloid of Erythroxylum coca, a shrub native to the Andean highlands of South America. The genus Erythroxylum contains over 250 species, but three carry commercially relevant cocaine levels: E. coca var. coca (cultivated in Peru and Bolivia, predominantly for traditional chewing and coca tea), E. coca var. ipadu (Amazon basin, lower alkaloid content), and E. novogranatense var. novogranatense (Colombia, the dominant species in the industrial trafficking supply chain). The alkaloid content of leaves ranges from 0.5 to 1.5 per cent w/w; Colombian material typically sits at 0.8-1.2 per cent.
Test yourself on Forensic Chemistry with free, timed mocks.
Practice Forensic Chemistry questionsThe extraction sequence from leaf to cocaine hydrochloride, sometimes called the "Colombian process" in UNODC technical documentation:
Crack cocaine is produced by a simple reversal: cocaine HCl is dissolved in water, treated with baking soda (sodium bicarbonate) or ammonia, and the freebase that precipitates is dried. The "crack" sound (and name) comes from the popping of sodium bicarbonate residues in the freebase when heated. Crack is smoked because the freebase has a melting point of 98°C and volatilises without decomposition; the HCl salt cannot be smoked effectively because it melts at 195°C with decomposition. This physical chemistry distinction is what drives the crack vs powder distinction in routes of administration and, consequently, in social epidemiology.
From a casework standpoint: cocaine HCl is confirmed by Scott test (cobalt thiocyanate in aqueous solution, then glycerine, then saturated sodium chloride; true positive gives blue precipitate in the organic layer), Marquis (orange-brown, differentiating from heroin's purple-black), and GC-MS (molecular ion m/z 303, base peak m/z 182 from benzoyl fragment loss, plus m/z 82, 94). Crack (cocaine freebase) gives the same GC-MS spectrum but may show different cutting-agent profiles. The freebase has higher GC-MS volatility and elutes approximately 0.5 minutes earlier than a polar reference standard injected in methanol; injection in ethyl acetate is recommended for crack to avoid conversion artefacts.
The levamisole contamination of the global cocaine supply is not an accident or a mistake, it is a consistent feature of the manufacturing process that now serves as a forensic marker linking seizures to South American production.
The cocaine supply chain involves cutting (adulteration to extend the product) at multiple stages from production to street level. The adulterant profile changes as the product moves down the supply chain and is therefore a fingerprint of how far along the distribution network a seized sample sits.
At the production level: pharmaceutical adulterants added in South American laboratories include levamisole (a veterinary antihelminthic, found in approximately 80 per cent of cocaine samples in North American and European monitoring since 2014), phenacetin (a now-banned analgesic with cocaine-potentiating perceived effect), and aminorex (a stimulant generated as a metabolic product of levamisole). Levamisole's prevalence is not fully explained: hypotheses include use as an immune system potentiator (disputed), co-extraction from coca plants grown in soils treated with levamisole-based pesticides (partially supported by agrochemical data), and direct addition at the production stage to increase perceived potency or reduce the cost of pure cocaine per weight unit.
At the trafficking and mid-level distribution stage: local anaesthetics (benzocaine, procaine, lidocaine) are added for their numbing effect that mimics cocaine's topical effect when rubbed on gums, making adulterated product more convincing to buyers. Benzocaine is the most common adulterant in UK and EU seizures by weight.
At the street level: mannitol, lactose, and inositol are used as bulking agents. These inert sugars give the product a visual and tactile texture similar to cocaine powder.
Isotope ratio mass spectrometry (IRMS) for source attribution: Stable isotope ratios (13C/12C expressed as delta-13C in per mille relative to Vienna Pee Dee Belemnite, and D/H) in cocaine reflect both the photosynthetic pathway of the coca plant (C3 pathway, with characteristic delta-13C around -28 to -32 per mille) and the local water and soil isotopic signatures. Colombian, Peruvian, and Bolivian cocaine populations have statistically distinct delta-13C profiles in the benzoyl ester and ecgonine methyl ester moieties. The Thermo Scientific DELTA V Advantage isotope ratio mass spectrometer, coupled with a preparative GC inlet for compound-specific IRMS (CSIA), is the instrument of choice. UNODC's Isotope Ratio Data Bank and the European Forensic Isotope Ratio Reference Database (EFI-RRD) provide reference isotope fingerprints for source-region comparison.
The 2023 Encrochat operation (a French-led law enforcement operation that compromised the Encrochat encrypted phone network used by European drug traffickers) produced a dataset of seized cocaine exhibits with documented supply chains. Isotope ratio analysis on these exhibits, performed by the Dutch NFI and the Bundeskriminalamt (BKA), confirmed the source attribution method's concordance with intelligence data: samples attributed to Colombian origin by IRMS matched supply chain intelligence pointing to FARC-dissident-affiliated production groups in the Nariño and Putumayo departments.
d-Methamphetamine is a potent CNS stimulant and a Schedule II controlled substance; l-methamphetamine is an over-the-counter nasal decongestant in the US and is not controlled. Distinguishing them analytically can make or break a prosecution.
Amphetamine (alpha-methylphenethylamine) and methamphetamine (N-methyl-alpha-methylphenethylamine) are chiral molecules, each existing as two non-superimposable mirror-image isomers (enantiomers): the dextrorotatory (d-, or R-,) and levorotatory (l-, or S-,) forms. The pharmacological consequences of this chirality are profound:
In casework, this distinction matters when a defendant claims that a methamphetamine seizure is consistent with OTC Vicks Inhaler rather than illicit product. The racemic mixture (50:50 d:l) produced by P2P synthesis or other non-stereoselective routes, and the nearly pure d-enantiomer produced by pseudoephedrine reduction (a stereospecific route), allow enantiomeric analysis to distinguish synthesis route:
Chiral gas chromatography on a Chirasil-DEX CB column (Agilent) or a Cyclosil-B column resolves d- and l-methamphetamine to baseline under standard conditions (column temperature 120°C, carrier He at 1.0 mL/min). The ratio is expressed as enantiomeric excess (ee). A high ee strongly implicates pseudoephedrine-reduction route (and therefore ephedrine/pseudoephedrine as the precursor, a controlled substance globally). Near-racemate implicates P2P or alternative non-stereospecific synthesis.
| Property | d-Methamphetamine | l-Methamphetamine | Racemic meth (P2P route) |
|---|---|---|---|
| CNS stimulant potency | High (primary illicit form) | Very low (OTC decongestant) | Intermediate (lower effective dose) |
| US CSA status | Schedule II (Desoxyn) | Not federally scheduled | Schedule II (racemic) |
| UK MDA status | Class B | Class B (any methamphetamine) | Class B |
| GC-MS alone distinguishes? | No (identical mass spectrum) | No (identical mass spectrum) | No (identical mass spectrum) |
Every clandestine methamphetamine synthesis route leaves a chemical signature in the product, and understanding the route chemistry tells you which precursors were controlled too late.
The clandestine synthesis of amphetamines has evolved through at least four major route generations, each driven by precursor scheduling that closed off the previous route and pushed chemists toward alternatives.
Leuckart reaction (amphetamine and methamphetamine): Phenylacetone (phenyl-2-propanone, P2P, also called benzyl methyl ketone, BMK) reacts with formamide in the Leuckart reaction to give an N-formyl intermediate, which is hydrolysed to give amphetamine, or reacts with N-methylformamide to give methamphetamine. The route is non-stereospecific, yielding racemic product. P2P was heavily used in European clandestine labs before it was placed under UN Convention Table I control in 1988 and under the EU Drug Precursors Regulation. After P2P scheduling, European labs shifted to other precursors; however, P2P synthesis has resurged since approximately 2020, with the DEA documenting a shift in the US methamphetamine supply from pseudoephedrine-reduction d-meth back toward racemic P2P-route meth. The DEA's 2022 drug threat assessment attributes this shift to enhanced pseudoephedrine/ephedrine scheduling reducing availability.
Birch reduction / Nazi method (methamphetamine): Ephedrine or pseudoephedrine is reduced using lithium or sodium metal dissolved in anhydrous ammonia (the Birch reduction conditions), with a proton source (t-BuOH or i-PrOH). The method is stereospecific: starting from pseudoephedrine (the 1S,2S enantiomer), the product is d-methamphetamine with high enantiomeric purity. This route dominated US methamphetamine production in the 1990s-2000s and is sometimes called the "Nazi method" (though the historical link to World War II German production is largely myth). Characteristic impurities from the Birch route include phenylacetone (trace) and 1-phenyl-2-propanol (from incomplete reduction).
Pseudoephedrine/ephedrine catalytic hydrogenation: Pseudoephedrine or ephedrine is treated with hydriodic acid (HI) and red phosphorus (or white phosphorus) as a catalyst, with HI generated in situ. This is a variation on the P-red method; the product is predominantly d-methamphetamine from pseudoephedrine. The Combat Methamphetamine Epidemic Act (US, 2005) placed pseudoephedrine and ephedrine in Schedule V of the CSA with purchase limits (3.6 g per day, 9 g per 30 days from behind-the-counter pharmacy sales), requiring ID verification and electronic logging. This is why pseudoephedrine-containing cold medicines (Sudafed) require pharmacy counter access in the US. India's NDPS Schedule III controls pseudoephedrine and ephedrine as controlled precursors; their import and export requires NCB/DEA country authorisation.
P2P reductive amination: Phenylacetone (P2P, BMK) is reductively aminated with methylamine and sodium cyanoborohydride or catalytic hydrogenation (Pd/C, H2) to give methamphetamine. Non-stereospecific. Characteristic impurities: dimethylamphetamine (from bis-methylation), unreacted P2P.
Identifying the synthesis route from the exhibit product uses: (1) enantiomeric ratio (chiral GC); (2) impurity profile (GC-MS detection of route-specific byproducts: P2P route shows dimethylamphetamine impurity; Birch route shows 1-phenyl-2-propanol; pseudoephedrine route may show residual pseudoephedrine). This impurity profiling is the basis for UNODC's methamphetamine signature program, which uses GC-MS data from national laboratories to build a supply-chain intelligence picture.
MDMA's supply chain runs from a safrole oil extraction facility in Southeast Asia through a Polish or Belgian synthesis lab and Dutch tablet press to a European festival, and at each stage a controlled precursor whose scheduling generated a substitute is the forensic fingerprint of that generation of supply.
MDMA (3,4-methylenedioxymethamphetamine) and its desmethyl analogue MDA (3,4-methylenedioxyamphetamine) belong to the methylenedioxy-substituted phenethylamine family. MDMA is the most commonly seized entactogen globally; EMCDDA data shows approximately 12 million European adults reporting use in 2023. MDA is less common in current seizures but was the dominant compound in the 1960s-1970s before MDMA was popularised.
The key precursor for MDMA synthesis is the methylenedioxyphenyl moiety, introduced via either safrole (4-allyl-1,2-methylenedioxybenzene, extracted from sassafras oil from Cinnamomum camphora trees in Cambodia, Vietnam, and Brazil) or isosafrole (the double-bond isomer). Safrole was placed under Table I of the UN 1988 Convention following evidence of its use as the primary MDMA precursor in the late 1980s and early 1990s. In 2008, UNODC and INTERPOL Operation Purple disrupted safrole oil trafficking from Cambodia, which had supplied European MDMA labs.
After safrole scheduling, clandestine chemists shifted to precursor substitutes:
MDMA synthesis routes: the Wacker oxidation of safrole or isosafrole to PMK, followed by reductive amination with methylamine (analogous to the P2P-methylamine route for methamphetamine). The product is racemic MDMA; there is no stereospecific route that dominates the clandestine supply, so the enantiomeric ratio of seized MDMA is typically near-racemic (unlike d-meth from pseudoephedrine reduction). Both the R- and S-enantiomers of MDMA have similar entactogenic activity.
Casework identification: Scott test is negative (cobalt thiocyanate is specific for cocaine). Marquis reagent gives a distinctive purple-black for MDMA (slower than heroin; approximately 30-60 seconds). Mecke reagent gives blue-green. GC-MS: MDMA molecular ion m/z 193, base peak m/z 58 (CH2=NHCH3+, methyliminium cation). MDA differs by 14 Da (m/z 179) with base peak m/z 44. The 14 Da difference and the base peak at m/z 44 vs 58 definitively distinguishes MDA from MDMA. LC-MS/MS is used for quantification in tablet content analysis.
MDMA tablet analysis: seized MDMA tablets show enormous variation in content. A 2023 EMCDDA drug market report cites a range from 50 mg to 340 mg MDMA per tablet in EU seizures, with an average of approximately 145 mg. Tablets exceeding 200 mg (dubbed "super pills") are associated with overdose risk. The Bruker Alpha FTIR-ATR is used by Dutch, Belgian, and German drug-checking services (pill-testing programmes) for rapid MDMA confirmation; dose quantification requires LC-MS/MS. India does not have an operational pill-testing programme; MDMA seizures go directly to FSL for identification under NDPS psychotropic schedule provisions.
A cocaine seizure involving levamisole, a methamphetamine seizure where the enantiomeric ratio is central to the charge, and an MDMA tablet with an unstated dose all require the same core instruments but different method extensions, and the analyst who conflates these workflows will produce a report that fails under cross-examination.
Stimulant casework combines classical colour chemistry, chromatographic separation, and mass spectrometric confirmation, with chiral GC and IRMS as method extensions for specific analytical questions.
Cocaine workflow: Scott test (presumptive); GC-MS (Category A confirmation, Agilent 7890/5977, HP-5MS, molecular ion m/z 303, m/z 182 base peak); LC-MS/MS quantification (Waters Xevo TQ-S, MRM 304.1→182.1 quantifier, 304.1→82.1 qualifier); levamisole co-analysis (LC-MS/MS, MRM 205.1→91.1); IRMS for source attribution (Thermo DELTA V, delta-13C in benzoyl ester moiety by preparative GC-IRMS).
Methamphetamine workflow: Marquis test (orange-brown response for amphetamines; weaker than heroin response); GC-MS on achiral column (confirmation, m/z 58 base peak for methamphetamine, m/z 91, 65, 44); chiral GC (Chirasil-DEX CB column, 25 m, 0.25 mm ID; baseline resolution of d- and l-enantiomers at 110°C isothermal; enantiomeric excess reported as % d over total meth); impurity profiling (look for P2P, dimethylamphetamine, phenylacetone, or 1-phenyl-2-propanol to infer synthesis route); LC-MS/MS quantification.
MDMA/MDA workflow: Marquis test (purple-black, slower than heroin); Mecke (blue-green); GC-MS (m/z 193 for MDMA, m/z 179 for MDA; base peak m/z 58 vs 44 for the two compounds); LC-MS/MS tablet content quantification (Waters Xevo TQ-S, MRM 194.1→163.1 for MDMA, 180.1→163.1 for MDA); chiral GC if enantiomeric purity is in question (uncommon in standard casework but relevant in research or pharmaceutical diversion cases).
High-resolution MS for novel stimulants: For novel cathinones or unscheduled designer stimulants, the Thermo Q Exactive or Bruker timsTOF are used for exact mass determination and fragmentation pattern analysis. An exact mass at 5 ppm accuracy within the observed molecular formula allows confident structural assignment even without a reference standard, subject to the caveat that this constitutes a putative identification only.
A forensic chemist analyses a methamphetamine exhibit by chiral GC (Chirasil-DEX CB column) after HFBA derivatisation. The chromatogram shows a d:l peak area ratio of 49:51. What is the most likely clandestine synthesis route for this exhibit?
| Chiral GC distinguishes? | Yes (longer retention on Chirasil-DEX) | Yes (shorter retention) | Yes (equal peaks) |
| Synthesis route implied | Pseudoephedrine / ephedrine reduction (stereospecific) | Vicks Inhaler OTC product | P2P reductive amination (non-stereospecific) |